Guard Medical Inc.
$77.8K 295 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
TearLab Corp
TearLab Corp reported $77,797.70 across General Payments, Research, and Ownership to 325 physicians and teaching hospitals across 325 transactions.
- $77.8K Below-median payer
- All-tracks total
- 325 Above-median volume
- Transactions
- 325 Above-median reach
- Recipients
- −$99.5K
- General Payments vs PY2023
TearLab Corp reported $77,797.70 across all CMS Open Payments tracks (General + Research + Ownership) to 325 physicians and teaching hospitals in Program Year 2024 - ranking #1247 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $77,797.70, averaging $239.38 per recipient.
How TearLab Corp's $77.8K all-tracks total breaks down
TearLab Corp's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
28/100
Total payments
F
11/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer tearlab-corp TearLab Corp
$77.8K · #1247/1,925 · 0.0% industry · PY2024
- TOT $77.8K
- RANK #1247
- SHARE 0.0%
- TXN 325
- RCP 325
- CAT 6
- GEN $77.8K
- ΔGEN −$99.5K
- TOP1 25.7%
- PY 2024
Volume peers
Nearest volume peer: Guard Medical Inc. ($77.8K)
TearLab Corp sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
TearLab Corp's CMS-reported General Payments decreased by $99.5K (−56.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: TEARLAB CORPPY2023: TEARLAB CORPPY2024: TearLab Corp. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $177,308.51
- PY2024
- $77,797.70
What the Data Shows for TearLab Corp
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For TearLab Corp, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
22 transactions worth $32.3K make "Consulting Fee" the top general-payment category in the 6-category breakdown below, 41.5% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 6 types of general payments, TearLab Corp's largest category was "Consulting Fee" at $32.3K - 41.5% of General Payments.
TearLab Corp reports 6 general-payment categories - the top three are Consulting Fee (41.5%), Honoraria (25.7%), and Gift (13.3%). The remaining 3 categories make up 19.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How TearLab Corp divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $32.3K | 22 | 41.5% |
| Honoraria | $20.0K | 2 | 25.7% |
| Gift | $10.4K | 8 | 13.3% |
| Food and Beverage | $8.8K | 285 | 11.3% |
| Compensation for Faculty or Speaker (Medical Education) | $6.3K | 7 | 8.1% |
| Travel and Lodging | $19.17 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $45,547.34 (58.5%) of $77,797.70 in this company's General Payments records across 270 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for TearLab Corp
The five named recipients with the highest reported General Payments from this company
- 1
Richard Lindstrom
$20,000.00 across 2 reported transactions
- 2
Lisa Nijm
$11,447.34 across 4 reported transactions
- 3
Eric Donnenfeld
$10,000.00 across 1 reported transactions
- 4
Kenneth Beckman
$2,100.00 across 2 reported transactions
- 5
Damon Dierker
$2,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
TearLab Corp's spend rank (#1247 of 1,925, bottom 35% by spend) and concentration rank (#987 of 1,838, bottom 46% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- MeMed US, Inc. : $7.7K total payments, HHI 1121
- MiRus, LLC : $236.9K total payments, HHI 1119
- Echosens North America, Inc. : $149.4K total payments, HHI 1118
- Curium US LLC : $45.9K total payments, HHI 1118
- Noah Medical Corporation : $1.2M total payments, HHI 1114
- Life Technologies Corporation : $868.1K total payments, HHI 1114
- TearLab Corp (this company) : $77.8K total payments, HHI 1113
- American Regent : $64.2K total payments, HHI 1109
- Rigicon,Inc. : $933.53 total payments, HHI 1108
- Monteris Medical Corporation : $197.5K total payments, HHI 1107
- Nuwellis, Inc. : $242.8K total payments, HHI 1104
- GM Pharmaceuticals, Inc. : $1.8K total payments, HHI 1093
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as TearLab Corp's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about TearLab Corp.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with TearLab Corp.
Showing 6 of 1,924 companies with CMS-reported payment data.
Team 1, Llc
$78.3K 409 recipients
Compare payment profiles
Prodigy Surgical Distribution, Inc.
$78.3K 292 recipients
Compare payment profiles
Daiichi Sankyo Europe GmbH
$77.3K 33 recipients
Compare payment profiles
Voom Medical Devices, Inc.
$76.9K 190 recipients
Compare payment profiles
Visionary Optics LLC
$78.8K 119 recipients
Compare payment profiles
Put this to use
TearLab Corp ranks #1247 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just TearLab Corp. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.